Skip to main content
Erschienen in: Strahlentherapie und Onkologie 1/2018

15.09.2017 | Original Article

Air–electron stream interactions during magnetic resonance IGRT

Skin irradiation outside the treatment field during accelerated partial breast irradiation

verfasst von: Jong Min Park, Kyung Hwan Shin, Jung-in Kim, So-Yeon Park, Seung Hyuck Jeon, Noorie Choi, Jin Ho Kim, Hong-Gyun Wu

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate and to prevent irradiation outside the treatment field caused by an electron stream in the air generated by the magnetic field during magnetic resonance image-guided accelerated partial breast irradiation (APBI).

Materials and methods

In all, 20 patients who received APBI with a magnetic resonance image-guided radiation therapy (MR-IGRT) system were prospectively studied. The prescription dose was 38.5 Gy in 10 fractions of 3.85 Gy and delivered with a tri-cobalt system (the ViewRay system). For each patient, primary plans were delivered for the first five fractions and modified plans with different gantry angles from those of the primary plan (in-treatment plans) were delivered for the remaining five fractions to reduce the skin dose. A 1 cm thick bolus was placed in front of the patient’s jaw, ipsilateral shoulder, and arm to shield them from the electron stream. Radiochromic EBT3 films were attached to the front (towards the breast) and back (towards the head) of the bolus during treatment. Correlations between the measured values and the tumor locations, treatment times, and tumor sizes were investigated.

Results

For a single fraction delivery, the average areas of the measured isodoses of 14% (0.54 Gy), 12% (0.46 Gy), and 10% (0.39 Gy) at the front of the boluses were as large as 3, 10.4, and 21.4 cm2, respectively, whereas no significant dose could be measured at the back of the boluses. Statistically significant but weak correlations were observed between the measured values and the treatment times.

Conclusion

During radiotherapy for breast cancer with an MR-IGRT system, the patient must be shielded from electron streams in the air generated by the interaction of the magnetic field with the beams of the three-cobalt treatment unit to avoid unwanted irradiation of the skin outside the treatment field.
Literatur
1.
Zurück zum Zitat Correa C, Harris EE, Leonardi MC et al (2017) Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement. Pract Radiat Oncol 7:73–79CrossRefPubMed Correa C, Harris EE, Leonardi MC et al (2017) Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement. Pract Radiat Oncol 7:73–79CrossRefPubMed
2.
Zurück zum Zitat Smith BD, Arthur DW, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74:987–1001CrossRefPubMed Smith BD, Arthur DW, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74:987–1001CrossRefPubMed
3.
Zurück zum Zitat Polgar C, Van Limbergen E, Potter R et al (2009) Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence. Radiother Oncol 94:264–273CrossRef Polgar C, Van Limbergen E, Potter R et al (2009) Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence. Radiother Oncol 94:264–273CrossRef
4.
Zurück zum Zitat Chang JH, Lee NK, Kim JY et al (2013) Phase II trial of proton beam accelerated partial breast irradiation in breast cancer. Radiother Oncol 108:209–214CrossRefPubMed Chang JH, Lee NK, Kim JY et al (2013) Phase II trial of proton beam accelerated partial breast irradiation in breast cancer. Radiother Oncol 108:209–214CrossRefPubMed
5.
Zurück zum Zitat Sayan M, Wilson K, Nelson C, Gagne H (2017) Rubin D Heimann R. A novel schedule of accelerated partial breast radiation using intensity-modulated radiation therapy in elderly patients: survival and toxicity analysis of a prospective clinical trial. Radiat Oncol J 35:32–38CrossRefPubMedPubMedCentral Sayan M, Wilson K, Nelson C, Gagne H (2017) Rubin D Heimann R. A novel schedule of accelerated partial breast radiation using intensity-modulated radiation therapy in elderly patients: survival and toxicity analysis of a prospective clinical trial. Radiat Oncol J 35:32–38CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Sung K, Lee KC, Lee SH (2014) Ahn SH Choi J. Cardiac dose reduction with breathing adapted radiotherapy using self respiration monitoring system for left-sided breast cancer. Radiat Oncol J 32:84–94CrossRefPubMedPubMedCentral Sung K, Lee KC, Lee SH (2014) Ahn SH Choi J. Cardiac dose reduction with breathing adapted radiotherapy using self respiration monitoring system for left-sided breast cancer. Radiat Oncol J 32:84–94CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Vicini FA, Chen P, Wallace M et al (2007) Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 69:1124–1130CrossRefPubMed Vicini FA, Chen P, Wallace M et al (2007) Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 69:1124–1130CrossRefPubMed
8.
Zurück zum Zitat Rusthoven KE, Carter DL, Howell K et al (2008) Accelerated partial-breast intensity-modulated radiotherapy results in improved dose distribution when compared with three-dimensional treatment-planning techniques. Int J Radiat Oncol Biol Phys 70:296–302CrossRefPubMed Rusthoven KE, Carter DL, Howell K et al (2008) Accelerated partial-breast intensity-modulated radiotherapy results in improved dose distribution when compared with three-dimensional treatment-planning techniques. Int J Radiat Oncol Biol Phys 70:296–302CrossRefPubMed
9.
Zurück zum Zitat Oliver M, Chen J, Wong E, Van Dyk J, Perera F (2007) A treatment planning study comparing whole breast radiation therapy against conformal, IMRT and tomotherapy for accelerated partial breast irradiation. Radiother Oncol 82:317–323CrossRefPubMed Oliver M, Chen J, Wong E, Van Dyk J, Perera F (2007) A treatment planning study comparing whole breast radiation therapy against conformal, IMRT and tomotherapy for accelerated partial breast irradiation. Radiother Oncol 82:317–323CrossRefPubMed
10.
Zurück zum Zitat Park CK, Pritz J, Zhang GG, Forster KM, Harris EE (2012) Validating fiducial markers for image-guided radiation therapy for accelerated partial breast irradiation in early-stage breast cancer. Int J Radiat Oncol Biol Phys 82:e425–e431CrossRefPubMed Park CK, Pritz J, Zhang GG, Forster KM, Harris EE (2012) Validating fiducial markers for image-guided radiation therapy for accelerated partial breast irradiation in early-stage breast cancer. Int J Radiat Oncol Biol Phys 82:e425–e431CrossRefPubMed
11.
Zurück zum Zitat Wooten HO, Green O, Yang M et al (2015) Quality of Intensity Modulated Radiation Therapy Treatment Plans Using a (6)(0)Co Magnetic Resonance Image Guidance Radiation Therapy System. Int J Radiat Oncol Biol Phys 92:771–778CrossRefPubMed Wooten HO, Green O, Yang M et al (2015) Quality of Intensity Modulated Radiation Therapy Treatment Plans Using a (6)(0)Co Magnetic Resonance Image Guidance Radiation Therapy System. Int J Radiat Oncol Biol Phys 92:771–778CrossRefPubMed
12.
Zurück zum Zitat Wooten HO, Rodriguez V, Green O et al (2015) Benchmark IMRT evaluation of a Co-60 MRI-guided radiation therapy system. Radiother Oncol 114:402–405CrossRefPubMed Wooten HO, Rodriguez V, Green O et al (2015) Benchmark IMRT evaluation of a Co-60 MRI-guided radiation therapy system. Radiother Oncol 114:402–405CrossRefPubMed
13.
Zurück zum Zitat Park JM, Park S, Wu H, Kim J (2015) Commissioning experience of tri-cobalt-60 MRI-guided radiation therapy system. Prog Med Phys 26:193–200CrossRef Park JM, Park S, Wu H, Kim J (2015) Commissioning experience of tri-cobalt-60 MRI-guided radiation therapy system. Prog Med Phys 26:193–200CrossRef
14.
Zurück zum Zitat Mutic S, Dempsey JF (2014) The ViewRay system: magnetic resonance-guided and controlled radiotherapy. Semin Radiat Oncol 24:196–199CrossRefPubMed Mutic S, Dempsey JF (2014) The ViewRay system: magnetic resonance-guided and controlled radiotherapy. Semin Radiat Oncol 24:196–199CrossRefPubMed
15.
Zurück zum Zitat Kim J, Park S, Lee YH, Shin KH, Wu H, Park JM (2015) Effect of low magnetic field on dose distribution in the partial-breast irradiation. Prog Med Phys 26:208–214CrossRef Kim J, Park S, Lee YH, Shin KH, Wu H, Park JM (2015) Effect of low magnetic field on dose distribution in the partial-breast irradiation. Prog Med Phys 26:208–214CrossRef
17.
Zurück zum Zitat Kim JI, Park SY, Kim HJ, Kim JH, Ye SJ, Park JM (2014) The sensitivity of gamma-index method to the positioning errors of high-definition MLC in patient-specific VMAT QA for SBRT. Radiat Oncol 9:167CrossRefPubMedPubMedCentral Kim JI, Park SY, Kim HJ, Kim JH, Ye SJ, Park JM (2014) The sensitivity of gamma-index method to the positioning errors of high-definition MLC in patient-specific VMAT QA for SBRT. Radiat Oncol 9:167CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Reyhan ML, Chen T, Zhang M (2015) Characterization of the effect of MRI on Gafchromic film dosimetry. J Appl Clin Med Phys 16:5743CrossRef Reyhan ML, Chen T, Zhang M (2015) Characterization of the effect of MRI on Gafchromic film dosimetry. J Appl Clin Med Phys 16:5743CrossRef
19.
Zurück zum Zitat Micke A, Lewis DF, Yu X (2011) Multichannel film dosimetry with nonuniformity correction. Med Phys 38:2523–2534CrossRefPubMed Micke A, Lewis DF, Yu X (2011) Multichannel film dosimetry with nonuniformity correction. Med Phys 38:2523–2534CrossRefPubMed
20.
Zurück zum Zitat Ferreira BC, Lopes MC, Capela M (2009) Evaluation of an Epson flatbed scanner to read Gafchromic EBT films for radiation dosimetry. Phys Med Biol 54:1073–1085CrossRefPubMed Ferreira BC, Lopes MC, Capela M (2009) Evaluation of an Epson flatbed scanner to read Gafchromic EBT films for radiation dosimetry. Phys Med Biol 54:1073–1085CrossRefPubMed
21.
Zurück zum Zitat Lewis D, Chan MF (2015) Correcting lateral response artifacts from flatbed scanners for radiochromic film dosimetry. Med Phys 42:416–429CrossRefPubMed Lewis D, Chan MF (2015) Correcting lateral response artifacts from flatbed scanners for radiochromic film dosimetry. Med Phys 42:416–429CrossRefPubMed
22.
Zurück zum Zitat ICRP (2007) The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann. ICRP 37(2–4) ICRP (2007) The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann. ICRP 37(2–4)
Metadaten
Titel
Air–electron stream interactions during magnetic resonance IGRT
Skin irradiation outside the treatment field during accelerated partial breast irradiation
verfasst von
Jong Min Park
Kyung Hwan Shin
Jung-in Kim
So-Yeon Park
Seung Hyuck Jeon
Noorie Choi
Jin Ho Kim
Hong-Gyun Wu
Publikationsdatum
15.09.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 1/2018
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-017-1212-z

Weitere Artikel der Ausgabe 1/2018

Strahlentherapie und Onkologie 1/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.